Skip to main content

letter

. 1994 Aug 20;309(6953):541. doi: 10.1136/bmj.309.6953.541

Hazards of reducing cholesterol.

PMCID: PMC2542751 PMID: 7818653

541

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Dujovne C. A., Chremos A. N., Pool J. L., Schnaper H., Bradford R. H., Shear C. L., Higgins J., Downton M., Franklin F. A., Nash D. T. Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatin. Am J Med. 1991 Jul 31;91(1B):25S–30S. doi: 10.1016/0002-9343(91)90053-z. [DOI] [PubMed] [Google Scholar]
Law M. R., Thompson S. G., Wald N. J. Assessing possible hazards of reducing serum cholesterol. BMJ. 1994 Feb 5;308(6925):373–379. doi: 10.1136/bmj.308.6925.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
Muldoon M. F., Manuck S. B. Ischemic heart disease and cholesterol. Safety of cholesterol reduction remains in doubt. BMJ. 1994 Apr 23;308(6936):1104–1105. doi: 10.1136/bmj.308.6936.1104a. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES